This discussion explores the differences between a carnivore diet, the sugar diet concept, and GLP-1 medications. It looks at ...

Research suggests promising link between weight loss medication and eyesight.

An inquest is examining whether Mounjaro use or missed diagnostic opportunities contributed to a Norfolk woman’s death from ...

Health plans can use routine pharmacy claims to identify members at high risk for early discontinuation of glucagon-like peptide-1 receptor agonists and deliver targeted, equity-conscious adherence ...

Good afternoon, and thank you for joining us today to discuss LifeMD's results for the second quarter ending June 30, 2026. Joining the call today are Justin Schreiber, Chairman and Chief Executive ...

Spread the loveYou’ve done it. You’ve shed those stubborn pounds, perhaps through sheer willpower, rigorous diet, or even the aid of powerful new medications like Wegovy or Mounjaro. You feel lighter, ...

Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes ...

Struggling with weight loss isn’t a failure of willpower but often the result of complex biology, hormones and lifestyle factors working against you.

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company's ...

Second quarter 2026 revenue of $47.3 million, within the Company’s guidance range of $47 million to $50 million; adjusted EBITDA loss of ...

The 2027 Segal Health Plan Cost Trend Survey, the firm’s 30th annual survey of managed care organizations, health insurers, pharmacy benefit managers (PBMs), and third-party administrators (TPAs), ...